We address this topic to elucidate, through scientific data, a question that periodically resurfaces in alarming media reports: whether sports participation can, under certain circumstances, be detrimental and induce cardiac pathologies, specifically severe arrhythmias. Public anxiety is frequently exacerbated by incidents of sudden cardiac death in athletic venues. Due to the tragic nature of these events and the prominence of the athletes involved, such cases typically receive extensive media coverage.
The Beneficial Effects of Exercise
Let us examine the data more analytically, beginning with the positive cardiovascular adaptations and benefits of sports. Regular exercise has been definitively linked to improvements in arterial blood pressure, optimization of the lipid profile, and enhanced insulin sensitivity, which normalizes blood glucose levels.
Individuals who engage in regular physical activity typically reduce their risk factors for cardiovascular events (maintaining a normal body weight, abstaining from smoking, etc.), thereby securing a better prognosis regarding future cardiovascular morbidity. Furthermore, a series of beneficial effects of exercise have been established outside the cardiovascular system, including a reduced incidence of prostate and breast cancer, as well as the prevention of osteoporosis and dementia. Regarding life expectancy, observational studies suggest that elite athletes—such as Olympic medalists—live, on average, 3 years longer compared to individuals with similar demographic profiles in the general population.
Athlete’s Heart
Nevertheless, the intensive training of individuals systematically engaged in competitive sports induces structural changes in the heart, particularly within the myocardium. The heart adapts to meet the high hemodynamic demands imposed by rigorous exercise. This phenomenon is analogous to the hypertrophy and remodeling observed in skeletal muscles. Consequently, we frequently observe an increase in the internal dimensions of the cardiac chambers (both the left and right ventricles) alongside an increase in the wall thickness of the left ventricle.
Collectively, these physiological adaptations are clinically designated by the term "athlete’s heart". In the clinical evaluation of athletes, a recurring diagnostic dilemma is whether these structural alterations represent a benign physiological adaptation to exercise or mask an underlying pathological condition, such as early-stage dilated cardiomyopathy or hypertrophic cardiomyopathy. Fortunately, advanced diagnostic modalities allow clinicians, in the vast majority of cases, to differentiate benign physiological remodeling from true cardiac disease.
The primary screening tool utilized is the standard 12-lead electrocardiogram (ECG). Reflecting these structural modifications, the ECG of an athlete frequently demonstrates specific variations. It is imperative that the cardiologist is proficient in distinguishing expected, benign variants from suspicious or potentially pathological findings (Figure 1).
Arrhythmias
Within the context of intensive, high-performance athletic training, cardiac arrhythmias may occasionally manifest. Generally, the following dysrhythmias may be identified during the evaluation of athletes:
- Sinus Bradycardia and Atrioventricular (AV) Block: Due to a profound predominance of resting parasympathetic (vagal) tone, athletes typically exhibit a slow resting heart rate. Sinus bradycardia below 40 beats per minute is frequently documented. Additionally, a second-degree AV block (specifically Mobitz Type I or Wenckebach) is commonly observed during periods of rest or sleep. These conduction disturbances are entirely benign and should not cause clinical concern.
- Junctional or Idioventricular Rhythm: These rhythms emerge as a physiological escape mechanism resulting from marked deceleration of the sinus node firing rate. This allows a slightly faster escape rhythm to emerge from either the atrioventricular node (junctional rhythm) or the ventricles (idioventricular rhythm). This condition is also benign and carries no adverse prognostic significance.
- Premature Ventricular Contractions (PVCs): This phenomenon can be observed in athletes and is clinically managed identically to its presentation in non-athletic populations. A thorough diagnostic workup must be initiated to definitively rule out underlying structural heart disease. Once structural pathology is excluded, these premature ventricular beats are classified as benign and do not warrant disqualification from athletic activities.
- Atrial Fibrillation (AF): Observational studies indicate that atrial fibrillation has a higher incidence in athletes—particularly middle-aged individuals between 30 and 40 years of age—compared to sedentary individuals with otherwise identical baseline characteristics. Atrial fibrillation is a supraventricular tachyarrhythmia characterized by rapid, uncoordinated, and ineffective atrial contractions, which simultaneously generates a rapid and irregular ventricular response. While AF frequently provokes symptoms, when it occurs in otherwise healthy individuals, it typically does not harbor other adverse long-term sequelae. The etiology of atrial fibrillation is generally multifactorial; however, it most frequently manifests in patients with specific structural cardiac diseases. For instance, patients with mitral stenosis—a condition that mechanically impedes blood flow from the left atrium to the left ventricle—experience severe left atrial dilation, a known trigger for AF. Nevertheless, atrial fibrillation does not develop in all patients with mitral stenosis; some maintain normal sinus rhythm even in advanced stages of the disease. This clearly underscores that the manifestation of AF is modulated by additional factors, particularly intrinsic, constitutional traits. A highly analogous mechanism likely operates in intensive, competitive sports. It is hypothesized that the conditions of extreme volume and pressure overload imposed on the cardiac chambers create an arrhythmogenic substrate for atrial fibrillation only in a very small minority of individuals who possess a specific genetic or constitutional predisposition. Regardless of the underlying etiology, the documentation of atrial fibrillation in an athlete must immediately trigger a comprehensive diagnostic protocol to exclude any occult pathological conditions.
- Supraventricular Tachycardias (AV Nodal Reentrant Tachycardia, Accessory Pathway-Mediated Tachycardias): The incidence of these paroxysmal tachycardias demonstrates no causal relationship with athletic training. They manifest with identical prevalence in both athletes and the general population, and their therapeutic management remains entirely uniform across both groups.
- Ventricular Tachycardias: The detection of ventricular tachycardia necessitates the immediate cessation of competitive athletic activities and mandates an exhaustive diagnostic evaluation. The primary objective is to uncover any underlying structural heart disease or primary cardiac channelopathy (electrical disorder) that could account for these malignant ventricular rhythms. If no underlying structural or electrical pathology is identified, the arrhythmia is classified as idiopathic ventricular tachycardia. This condition is highly amenable to definitive treatment via catheter ablation, which represents the therapeutic strategy of choice to safely permit the athlete’s return to competitive sports.
Sudden Cardiac Death in Athletes
Whether the absolute risk of sudden cardiac death (SCD) is higher in competitive athletes remains unresolved by epidemiological data. While historical cohorts from Padua, Italy, reported an elevated relative risk, these findings have not been consistently replicated by alternative epidemiological registries across Europe and the United States.
Nevertheless, there is global clinical consensus that individuals in whom pre-participation screening uncovers a cardiac pathology capable of predisposing them to sudden death must refrain, at minimum, from competitive sports in a concerted effort to mitigate this risk. This screening strategy, systematically implemented over several decades in Italy, appears to have successfully reduced the incidence of sudden cardiac death during sports from 3.6 per 100,000 individuals annually two decades ago, down to 0.4 per 100,000 individuals annually today.
It is worth noting that modern sports cardiology now permits elite athletes who have sustained a major cardiac event to safely return to active competition following the successful implantation of a subcutaneous cardioverter-defibrillator (S-ICD). This device serves as a permanent fail-safe mechanism, continuously monitoring, identifying, and immediately terminating potentially lethal arrhythmias during physical exertion. Subject to a rigorous, individualized shared decision-making process and a structured cardiac rehabilitation protocol, these athletes can successfully continue competing at the highest level of professional sports, including elite football.
What should constitute a comprehensive pre-participation screening protocol? In our country, a standardized practice has been firmly established in recent years: all individuals engaging in organized sports, whether during childhood or later in life, undergo a routine cardiovascular clinical examination and a 12-lead ECG. If clinically indicated—a scenario that practically extends to the vast majority of athletes—this protocol is supplemented by a transthoracic echocardiogram.
Another facet that demands equal clinical priority to pre-participation screening is the mandatory availability of Automated External Defibrillators (AEDs) within athletic facilities. Such devices, prominently positioned in a highly visible location akin to a fire extinguisher, can directly preserve life during a sudden cardiac arrest. They are engineered for ease of use, requiring minimal training. In our expert opinion, the physical presence of an operational AED within sports venues is arguably more critical and valuable than the physical presence of a physician.
Misuse of Performance-Enhancing Substances
The hyper-competitive nature of modern sports, immense media exposure, and the magnitude of financial rewards constitute primary drivers behind the escalating phenomenon of doping. This occurs despite well-documented catastrophic health consequences and stringent anti-doping controls designed to deter it.
Substances such as anabolic-androgenic steroids, cocaine, and ephedrine can acutely interact with a previously silent arrhythmogenic substrate. This interaction can trigger catastrophic clinical events, culminating in the sudden death of the athlete. Table 1 delineates these various illicit substances and their corresponding adverse effects on the cardiovascular system. It is profoundly evident that the vast majority of these performance-enhancing agents directly promote arrhythmogenesis and elevate the risk of sudden cardiac death.
Conclusions
Sports participation is robustly associated with a multitude of beneficial physiological effects, spanning both the cardiovascular and extra-cardiovascular systems. The physiological demand for an increased cardiac output to satisfy the metabolic requirements of intensive training induces adaptive structural changes in the myocardium. These benign adaptations can occasionally exhibit a phenotypic overlap with true cardiomyopathies.
The presentation of cardiac arrhythmias may serve as an early sentinel sign of an underlying, occult pathological state, which must be comprehensively investigated and diagnosed—a task that is often clinically challenging. The only dysrhythmias demonstrated to possess a direct causal relationship with regular athletic conditioning are bradyarrhythmias (specifically sinus bradycardia and certain types of benign AV block) and atrial fibrillation.
Crucially, even these specific arrhythmias carry a benign prognosis provided they occur in the absolute absence of concurrent structural cardiac disease or associated metabolic risk factors. For the vast majority of other arrhythmias, evidence indicates that intensive exercise does not directly cause the underlying pathology, but rather acts as an acute hemodynamic trigger that unmasks it. Consequently, these findings reinforce the absolute necessity of rigorous medical screening for all individuals engaged in systematic training. This diagnostic evaluation must become progressively more exhaustive whenever clinical findings deviate from established physiological norms.

Figure 1.


Figure 2. Three electrocardiograms: a) normal, b) a black athlete, c) a black athlete with hypertrophic cardiomyopathy. The points of divergence from normal are indicated by the red circles.
Table 1. The effect of performance-enhancing substances on the cardiovascular system.